Inogen Return on Tangible Equity 2012-2024 | INGN
Inogen Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2024-06-30 | $-0.09B | $0.14B | -58.75% |
2024-03-31 | $-0.10B | $0.15B | -53.12% |
2023-12-31 | $-0.10B | $0.16B | -49.22% |
2023-09-30 | $-0.13B | $0.19B | -56.54% |
2023-06-30 | $-0.10B | $0.24B | -38.11% |
2023-03-31 | $-0.09B | $0.25B | -34.48% |
2022-12-31 | $-0.08B | $0.26B | -31.61% |
2022-09-30 | $-0.05B | $0.26B | -18.59% |
2022-06-30 | $-0.03B | $0.27B | -10.11% |
2022-03-31 | $-0.02B | $0.27B | -7.19% |
2021-12-31 | $-0.01B | $0.28B | -2.54% |
2021-09-30 | $0.01B | $0.30B | 4.10% |
2021-06-30 | $-0.00B | $0.27B | -1.17% |
2021-03-31 | $-0.01B | $0.26B | -2.00% |
2020-12-31 | $-0.01B | $0.25B | -2.45% |
2020-09-30 | $-0.00B | $0.25B | -0.83% |
2020-06-30 | $0.01B | $0.25B | 2.95% |
2020-03-31 | $0.01B | $0.24B | 5.43% |
2019-12-31 | $0.02B | $0.23B | 7.58% |
2019-09-30 | $0.03B | $0.23B | 10.87% |
2019-06-30 | $0.04B | $0.33B | 13.30% |
2019-03-31 | $0.05B | $0.32B | 15.78% |
2018-12-31 | $0.05B | $0.30B | 19.10% |
2018-09-30 | $0.04B | $0.29B | 16.32% |
2018-06-30 | $0.03B | $0.26B | 13.66% |
2018-03-31 | $0.03B | $0.24B | 11.36% |
2017-12-31 | $0.02B | $0.22B | 9.59% |
2017-09-30 | $0.03B | $0.22B | 13.07% |
2017-06-30 | $0.02B | $0.20B | 13.06% |
2017-03-31 | $0.02B | $0.19B | 13.57% |
2016-12-31 | $0.02B | $0.18B | 12.84% |
2016-09-30 | $0.02B | $0.16B | 13.22% |
2016-06-30 | $0.02B | $0.15B | 12.39% |
2016-03-31 | $0.01B | $0.14B | 9.81% |
2015-12-31 | $0.01B | $0.13B | 9.34% |
2015-09-30 | $0.01B | $0.13B | 7.23% |
2015-06-30 | $0.01B | $0.13B | 6.64% |
2015-03-31 | $0.01B | $0.12B | 6.03% |
2014-12-31 | $0.01B | $0.12B | 4.44% |
2014-09-30 | $0.03B | $0.11B | 26.80% |
2014-06-30 | $0.02B | $0.11B | 33.58% |
2013-12-31 | $0.02B | $0.06B | 142.86% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.260B | $0.316B |
Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $234.603B | 28.12 |
Intuitive Surgical (ISRG) | United States | $174.618B | 98.87 |
Alcon (ALC) | Switzerland | $48.644B | 34.24 |
IQVIA Holdings (IQV) | United States | $43.639B | 24.73 |
IDEXX Laboratories (IDXX) | United States | $42.090B | 50.63 |
Edwards Lifesciences (EW) | United States | $41.782B | 26.78 |
DexCom (DXCM) | United States | $28.087B | 40.05 |
STERIS (STE) | Ireland | $24.036B | 28.05 |
SONOVA HOLDING (SONVY) | Switzerland | $21.526B | 0.00 |
Waters (WAT) | United States | $19.509B | 29.08 |
Hologic (HOLX) | United States | $19.209B | 20.88 |
Sysmex ADR (SSMXY) | Japan | $12.323B | 38.64 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.282B | 13.77 |
Teleflex (TFX) | United States | $11.593B | 18.03 |
Globus Medical (GMED) | United States | $9.474B | 26.50 |
Penumbra (PEN) | United States | $7.289B | 75.67 |
Glaukos (GKOS) | United States | $6.829B | 0.00 |
Masimo (MASI) | United States | $6.063B | 32.47 |
TransMedics (TMDX) | United States | $5.044B | 216.01 |
Integer Holdings (ITGR) | United States | $4.288B | 25.07 |
PROCEPT BioRobotics (PRCT) | United States | $4.258B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.795B | 0.00 |
Inari Medical (NARI) | United States | $2.695B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.649B | 15.54 |
Nihon Kohden (NHNKY) | Japan | $2.633B | 16.38 |
Veracyte (VCYT) | United States | $2.583B | 160.14 |
Elekta AB (EKTAY) | Sweden | $2.438B | 19.86 |
RxSight (RXST) | United States | $2.054B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.344B | 6.12 |
Pulse Biosciences (PLSE) | United States | $1.250B | 0.00 |
OPKO Health (OPK) | United States | $1.144B | 0.00 |
Silk Road Medical (SILK) | United States | $1.117B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.112B | 19.84 |
Artivion (AORT) | United States | $1.063B | 97.61 |
Alphatec Holdings (ATEC) | United States | $0.830B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.665B | 16.80 |
SiBone (SIBN) | United States | $0.647B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.631B | 0.00 |
AxoGen (AXGN) | United States | $0.626B | 0.00 |
IRadimed (IRMD) | United States | $0.622B | 33.60 |
Paragon 28 (FNA) | United States | $0.590B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.504B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.342B | 0.00 |
Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.332B | 10.14 |
Treace Medical Concepts (TMCI) | United States | $0.312B | 0.00 |
AngioDynamics (ANGO) | United States | $0.302B | 0.00 |
Delcath Systems (DCTH) | United States | $0.264B | 0.00 |
Accuray (ARAY) | United States | $0.216B | 0.00 |
Nevro (NVRO) | United States | $0.215B | 0.00 |
NeuroPace (NPCE) | United States | $0.204B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
Semler Scientific (SMLR) | United States | $0.178B | 12.46 |
CVRx (CVRX) | United States | $0.167B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
908 Devices (MASS) | United States | $0.126B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.120B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.110B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.100B | 14.93 |
Hyperfine (HYPR) | United States | $0.075B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
InspireMD (NSPR) | Israel | $0.067B | 0.00 |
Envoy Medical (COCH) | United States | $0.065B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
LENSAR (LNSR) | United States | $0.049B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.040B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
ReWalk Robotics (LFWD) | United States | $0.028B | 0.00 |
DarioHealth (DRIO) | United States | $0.027B | 0.00 |
Neuronetics (STIM) | United States | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
Spectral AI (MDAI) | United States | $0.022B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
PAVmed (PAVM) | United States | $0.018B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.017B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
Tenon Medical (TNON) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |